Cwm, LLC Aadi Bioscience, Inc. Transaction History

Cwm, LLC

$20.6 Billion
Q1 2024

A detailed history of Cwm, LLC transactions in Aadi Bioscience, Inc. stock. As of the latest transaction made, Cwm, LLC holds 25 shares of AADI stock, worth $36. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 25 -0.0%

Holding current value

$36

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2023 Feb 01, 2024	SELL	$1.97 - $5.41 $104 - $286	-53 Reduced 67.95%	25 $0
Q3 2023 Oct 11, 2023	BUY	$4.84 - $7.13 $377 - $556	78 New	78 $0

Others Institutions Holding AADI

# of Institutions

Shares Held

13.7M

Call Options Held

4.9K

Put Options Held

700

Avoro Capital Advisors LLC New York, NY

2.85M
Shares

$4.16 Million
0.08% of portfolio
Acuta Capital Partners, LLC Belmont, CA

1.85M
Shares

$2.7 Million
3.54% of portfolio
Satter Management Co., L.P.

1.63M
Shares

$2.38 Million
4.26% of portfolio
Black Rock Inc. New York, NY

1.04M
Shares

$1.52 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

857K
Shares

$1.25 Million
0.0% of portfolio

View Full List

About Aadi Bioscience, Inc.

Ticker AADI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,016,800
Market Cap $30.7M
Description
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...

More about AADI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account